This content is machine translated Moderate to severe atopic dermatitis JAK inhibitor upadacitinib a clear winner in comparative study with dupilumab The development of innovative drugs for the treatment of atopic dermatitis (AD) is increasingly focused on targeted therapies that selectively interfere with disease-causing signaling pathways [1]. That the Janus kinase…
View Post 2 min This content is machine translated Time flexible long-term ECG Relief through efficient solution for remote cardiology care Swiss healthcare provider evismo has collaborated with Finnish medical technology specialist Bittium to implement a solution for the growing demand for long-term ECGs. Flexible, wireless and with maximum diagnostic reliability,…
View Post 2 min This content is machine translated Alopecia areata Baricitinib improves hair growth in second Phase III study New data confirm the results of the first Phase III study published earlier this year. In both studies, a significantly higher proportion of baricitinib-treated patients met the primary endpoint of…
View Post 3 min This content is machine translated Subsyndromal and Generalized Anxiety Disorder (GAS) Phytotherapeutic relieves somatic symptoms accompanying anxiety Sub-syndromal and generalized anxiety disorders are common disorders. If left untreated, anxiety disorders can be associated with significant psychosocial consequences. Therefore, effective and well-tolerated therapeutic options are needed. A new…
View Post 4 min This content is machine translated Atopic dermatitis Dupilumab newly approved in Switzerland from 12 years of age Especially in adolescents, moderate to severe atopic dermatitis is associated with a high degree of suffering. In the pivotal study, dupilumab resulted in rapid and sustained relief of skin lesions…
View Post 5 min This content is machine translated News from the lung cancer pipeline First targeted substance in KRAS mutation and bispecific immunotherapy While targeted therapies in non-small cell lung cancer (NSCLC) have been on the rise for years, such an option for KRAS-mutatedtumors has been lacking. The small molecule inhibitor Sotorasib, which…
View Post 2 min This content is machine translated Atherosclerosis Revolutionary therapeutic approach for cholesterol reduction in the starting blocks A new drug could revolutionize the management of cholesterol lowering. In Vienna, a new agent was used for the first time in the clinic, which is expected to reduce LDL…
View Post 1 min This content is machine translated PAVK Low-dose paclitaxel coating also effective in balloons Recent two-year results from the COMPARE trial – the world’s first prospective, randomized, controlled head-to-head study of two drug-coated balloons – showed that the one coated with a lower dose…
View Post 3 min This content is machine translated Baricitinib First oral JAK inhibitor approved for the treatment of atopic dermatitis The use of small molecule drugs for the treatment of atopic dermatitis has been investigated for some time. With the approval of the Janus kinase (JAK) inhibitor baricitinib, a new…
View Post 3 min This content is machine translated Vesicoureteral reflux (VUR) Proven minimally invasive therapy option for children Vesicoureteral reflux affects approximately 1% of newborns. A gel composed of dextranomer and hyaluronic acid is a proven minimally invasive treatment option with proven efficacy. The therapy stops the reflux…
View Post 6 min This content is machine translated Atopic dermatitis “Itch-scratch-circle” interdisciplinary view and multimodal treatment In modern pathogenesis and treatment concepts, psychosocial dimensions are also included in the management of chronic dermatoses. Psychosocial stress is one of the trigger factors of atopic dermatitis and can…
